Schizophrenia Research
Volume 75, Issue 1 , Pages 143-146 , 1 June 2005

The soluble leptin receptor in olanzapine-induced weight gain: results from a prospective study

  • Christoph Ebenbichler

      Affiliations

    • Clinical Department of Internal Medicine, Clinical Division of General Internal Medicine, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 512 504 28537; fax: +43 512 504 28539.
    • ,
  • Markus Laimer

      Affiliations

    • Clinical Department of Internal Medicine, Clinical Division of General Internal Medicine, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria
    • ,
  • Susanne Baumgartner

      Affiliations

    • Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
    • ,
  • Monika Edlinger

      Affiliations

    • Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
    • ,
  • Alex Hofer

      Affiliations

    • Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
    • ,
  • Martina Hummer

      Affiliations

    • Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
    • ,
  • Michael Kranebitter

      Affiliations

    • Clinical Department of Internal Medicine, Clinical Division of General Internal Medicine, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria
    • ,
  • Monika Lechleitner

      Affiliations

    • Clinical Department of Internal Medicine, Clinical Division of General Internal Medicine, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria
    • ,
  • Josef R. Patsch

      Affiliations

    • Clinical Department of Internal Medicine, Clinical Division of General Internal Medicine, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria
    • ,
  • Maria A. Rettenbacher

      Affiliations

    • Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
    • ,
  • W. Wolfgang Fleischhacker

      Affiliations

    • Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria

Received 17 June 2004 ,Revised 29 October 2004 ,Accepted 30 October 2004.

References 

  1. Allison DB, Casey DE. Antipsychotic-induced weight gain: a review of the literature. J. Clin. Psychiatry. 2001;62:22–31
  2. American Diabetes Association , American Psychiatric Association , American Association of Clinical Endocrinologists , North American Association for the Study of Obesity . Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27:596–601
  3. Baumann G. Growth hormone binding protein-errant receptor or active player?. Endocrinology. 1995;136:377–378
  4. Bjorbaek C, Uotani S, da Silva B, Flier JS. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem. 1997;272:32686–32695
  5. Bromel T, Blum WF, Ziegler A, Schulz E, Bender M, Fleischhaker C, et al. Serum leptin levels increase rapidly after initiation of clozapine therapy. Mol. Psychiatry. 1998;3:76–80
  6. Chan JL, Bluher S, Yiannakouris N, Suchard MA, Kratzsch J, Mantzoros CS. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes. 2002;51:2105–2112
  7. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 1996;334:292–295
  8. Diamond FB, Eichler DC, Duckett G, Jorgensen EV, Shulman D, Root AW. Demonstration of a leptin binding factor in human serum. Biochem. Biophys. Res. Commun. 1997;233:818–822
  9. Ebenbichler CF, Laimer M, Eder U, Mangweth B, Weiss E, Hofer A, et al Olanzapine induces insulin resistance: results from a prospective study. J. Clin. Psychiatry. 2003;64:1436–1439
  10. Eder U, Mangweth B, Ebenbichler C, Weiss E, Hofer A, Hummer M, et al. Association of olanzapine-induced weight gain with an increase in body fat. Am. J. Psychiatry. 2001;158:1719–1722
  11. Ge H, Huang L, Pourbahrami T, Li C. Generation of soluble leptin receptor by ectodomain shedding of membrane-spanning receptors in vitro and in vivo. J. Biol. Chem. 2002;277:45898–45903
  12. Hagg S, Soderberg S, Ahren B, Olsson T, Mjorndal T. Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics. J. Clin. Psychiatry. 2001;62:843–848
  13. Houseknecht KL, Mantzoros CS, Kuliawat R, Hadro E, Flier JS, Kahn BB. Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes. 1996;45:1638–1643
  14. Laimer M, Ebenbichler CF, Kaser S, Sandhofer A, Weiss H, Nehoda H, et al. Weight loss increases soluble leptin receptor levels and the soluble receptor bound fraction of leptin. Obes. Res. 2002;10:597–601
  15. Lammert A, Kiess W, Bottner A, Glasow A, Kratzsch J. Soluble leptin receptor represents the main leptin binding activity in human blood. Biochem. Biophys. Res. Commun. 2001;283:982–988
  16. Landt M, Horowitz JF, Coppack SW, Klein S. Effect of short-term fasting on free and bound leptin concentrations in lean and obese women. J. Clin. Endocrinol. Metab. 2001;86:3768–3771
  17. Maamra M, Bidlingmaier M, Postel-Vinay MC, Wu Z, Strasburger CJ, Ross RJ. Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors. Endocrinology. 2001;142:4389–4393
  18. Melkersson K, Dahl ML. Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications. Drugs. 2004;64:701–723
  19. Muller-Newen G, Kohne C, Heinrich PC. Soluble receptors for cytokines and growth factors. Int. Arch. Allergy Immunol. 1996;111:99–106
  20. Ogier V, Ziegler O, Mejean L, Nicolas JP, Stricker-Krongrad A. Obesity is associated with decreasing levels of the circulating soluble leptin receptor in humans. Int. J. Obes. Relat. Metab. Disord. 2002;26:496–503
  21. Sandhofer A, Laimer M, Ebenbichler CF, Kaser S, Paulweber B, Patsch JR. Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome. Obes. Res. 2003;11:760–768
  22. Sartorius N, Fleischhacker WW, Gjerris A, Kern U, Knapp M, Leonhard B, et al. The usefulness and use of second generation antipsychotic medications. Curr. Opin. Psychiatry. 2002;15(Suppl. 1):S1–S51
  23. Sartorius N, Fleischhacker WW, Gjerris A, Kern U, Knapp M, Leonhard B, et al. The usefulness and use of second generation antipsychotic medications—an update. Curr. Opin. Psychiatry. 2003;16(Suppl. 1):S1–S44
  24. Sinha MK, Opentanova I, Ohannesian JP, Kolaczynski JW, Heiman ML, Hale J, et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J. Clin. Invest. 1996;98:1277–1282
  25. van Dielen FM, van ′t Veer C, Buurman WA, Greve JW. Leptin and soluble leptin receptor levels in obese and weight-losing individuals. J. Clin. Endocrinol. Metab. 2002;87:1708–1716

PII: S0920-9964(04)00417-7

doi: 10.1016/j.schres.2004.10.012

Schizophrenia Research
Volume 75, Issue 1 , Pages 143-146 , 1 June 2005

Article Tools